Literature DB >> 11403965

SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice.

D C Rogers1, J Peters, J E Martin, S Ball, S J Nicholson, A S Witherden, M Hafezparast, J Latcham, T L Robinson, C A Quilter, E M Fisher.   

Abstract

Mouse models of neurological abnormalities are only valuable if accurately assessed. The three-stage SHIRPA procedure is used for the standardised assessment of mouse phenotype and has been reported in a high throughput experiment in which different mutants were ascertained at one age point using stage 1 of the protocol. In this study we have validated SHIRPA using a large cohort with one single mutation, 'legs at odd angles that causes neurological dysfunction. The cohort aged from 1 to 16 months during this study and this is the first longitudinal SHIRPA analysis.

Entities:  

Mesh：

Year:  2001        PMID： 11403965     DOI： 10.1016/s0304-3940(01)01885-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  66 in total

1.  Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program.

Authors:  Hiroshi Masuya; Maki Inoue; Yumiko Wada; Aya Shimizu; Junko Nagano; Akiko Kawai; Ayako Inoue; Tomoko Kagami; Taeko Hirayama; Ayako Yamaga; Hideki Kaneda; Kimio Kobayashi; Osamu Minowa; Ikuo Miura; Yoichi Gondo; Tetsuo Noda; Shigeharu Wakana; Toshihiko Shiroishi
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

2.  Neuronal untranslated BC1 RNA: targeted gene elimination in mice.

Authors:  Boris V Skryabin; Valentina Sukonina; Ursula Jordan; Lars Lewejohann; Norbert Sachser; Ilham Muslimov; Henri Tiedge; Jürgen Brosius
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 3.  Translating therapies for Huntington's disease from genetic animal models to clinical trials.

Authors:  Steven M Hersch; Robert J Ferrante
Journal:  NeuroRx       Date:  2004-07

Review 4.  High-throughput mouse phenomics for characterizing mammalian gene function.

Authors:  Steve D M Brown; Chris C Holmes; Ann-Marie Mallon; Terrence F Meehan; Damian Smedley; Sara Wells
Journal:  Nat Rev Genet       Date:  2018-06       Impact factor: 53.242

5.  Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study.

Authors:  Silvia Mandillo; Valter Tucci; Sabine M Hölter; Hamid Meziane; Mumna Al Banchaabouchi; Magdalena Kallnik; Heena V Lad; Patrick M Nolan; Abdel-Mouttalib Ouagazzal; Emma L Coghill; Karin Gale; Elisabetta Golini; Sylvie Jacquot; Wojtek Krezel; Andy Parker; Fabrice Riet; Ilka Schneider; Daniela Marazziti; Johan Auwerx; Steve D M Brown; Pierre Chambon; Nadia Rosenthal; Glauco Tocchini-Valentini; Wolfgang Wurst
Journal:  Physiol Genomics       Date:  2008-05-27       Impact factor: 3.107

6.  Observational Evaluations of Mice during Cerebral Microdialysis for Pediatric Brain Tumor Research.

Authors:  Megan O Jacus; Richard J Rahija; Abigail D Davis; Stacy L Throm; Clinton F Stewart
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-05       Impact factor: 1.232

7.  Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy.

Authors:  Christine P Diggle; Stacey J Sukoff Rizzo; Michael Popiolek; Reetta Hinttala; Jan-Philip Schülke; Manju A Kurian; Ian M Carr; Alexander F Markham; David T Bonthron; Christopher Watson; Saghira Malik Sharif; Veronica Reinhart; Larry C James; Michelle A Vanase-Frawley; Erik Charych; Melanie Allen; John Harms; Christopher J Schmidt; Joanne Ng; Karen Pysden; Christine Strick; Päivi Vieira; Katariina Mankinen; Hannaleena Kokkonen; Matti Kallioinen; Raija Sormunen; Juha O Rinne; Jarkko Johansson; Kati Alakurtti; Laura Huilaja; Tiina Hurskainen; Kaisa Tasanen; Eija Anttila; Tiago Reis Marques; Oliver Howes; Marius Politis; Somayyeh Fahiminiya; Khanh Q Nguyen; Jacek Majewski; Johanna Uusimaa; Eamonn Sheridan; Nicholas J Brandon
Journal:  Am J Hum Genet       Date:  2016-04-07       Impact factor: 11.025

8.  Altered heparan sulfate structure in mice with deleted NDST3 gene function.

Authors:  Srinivas R Pallerla; Roger Lawrence; Lars Lewejohann; Yi Pan; Tobias Fischer; Uwe Schlomann; Xin Zhang; Jeffrey D Esko; Kay Grobe
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

9.  Neurodevelopmental impairment following neonatal hyperoxia in the mouse.

Authors:  Manimaran Ramani; Thomas van Groen; Inga Kadish; Arlene Bulger; Namasivayam Ambalavanan
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

10.  Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.

Authors:  Gareth T Banks; Virginie Bros-Facer; Hazel P Williams; Ruth Chia; Francesca Achilli; J Barney Bryson; Linda Greensmith; Elizabeth M C Fisher
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.